| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |